Efficacy and Safety of the DTS-G2 System in Patients With Axillary Hyperhidrosis

Inclusion Criteria: * baseline gravimetric measurement of spontaneous resting sweat production of at least 50 mg/5 min at room temperature in each axilla * poor quality-of-life rating on the Hyperhidrosis Disease Severity Scale * primary focal axillary hyperhidrosis evidenced by at least two of the standard criteria * female subjects of child-bearing potential must not be pregnant or lactating and must agree to not become pregnant during the course of the study including follow-up period * female subjects over 40 must have had a mammogram in the last 2 years * subjects must be willing to comply with study visits and requirements Exclusion Criteria: * subject has secondary hyperhidrosis (e.g., endocrinopathy, medications) * subject has active infection * subject is pregnant or lactating * subject has had prior surgery for axillary hyperhidrosis * subject has had axillary injections of botulinum toxin A in the last year * subject has used prescription antiperspirants in the last 14 days or plans to use them during the study period * subject has used oral anticholinergics in the last 4 weeks * subject is a prisoner or under incarceration * subject is participating in a another clinical trial (or has in the last 30 days) * subject has history of cancer (some exceptions) * subject has a pacemaker or other electronic implant * subject requires supplemental oxygen